ReviewClinical drug investigation2023

Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits?

Gabriella Chauca Strand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.